Biogen Inc
Символ: 0R1B.L
LSE
214.27113
USDПазарна цена днес
26.7401
Съотношение P/E
0.4580
Коефициент PEG
31.15B
MRK Cap
- 0.00%
Доходност на DIV
Biogen Inc (0R1B-L) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 14457.4 | 1049.9 | 4892.8 | 3802.5 | ||||||||||||
balance-sheet.row.short-term-investments | 5603.6 | 0 | 1473.5 | 1541.1 | ||||||||||||
balance-sheet.row.net-receivables | 8461.9 | 2100 | 2136.4 | 1961.7 | ||||||||||||
balance-sheet.row.inventory | 8124.3 | 2527.4 | 1344.4 | 1351.5 | ||||||||||||
balance-sheet.row.other-current-assets | 4464 | 1182 | 1417.6 | 740.8 | ||||||||||||
balance-sheet.row.total-current-assets | 35507.6 | 6859.3 | 9791.2 | 7856.5 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 14865.9 | 3729.7 | 3702.5 | 3791.8 | ||||||||||||
balance-sheet.row.goodwill | 24532.2 | 6219.2 | 5749 | 5761.1 | ||||||||||||
balance-sheet.row.intangible-assets | 10934.3 | 0 | 1850.1 | 2221.3 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 35466.5 | 6219.2 | 7599.1 | 7982.4 | ||||||||||||
balance-sheet.row.long-term-investments | 5033.2 | 460.7 | 1957.1 | 2602.2 | ||||||||||||
balance-sheet.row.tax-assets | 4418.6 | 928.6 | 1226.4 | 1415.1 | ||||||||||||
balance-sheet.row.other-non-current-assets | 9501.4 | 8647.3 | 277.8 | 229.3 | ||||||||||||
balance-sheet.row.total-non-current-assets | 69285.6 | 19985.5 | 14762.9 | 16020.8 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 104793.2 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.account-payables | 1780 | 403.3 | 491.5 | 589.2 | ||||||||||||
balance-sheet.row.short-term-debt | 740.3 | 240.3 | 97.2 | 1088.2 | ||||||||||||
balance-sheet.row.tax-payables | 996.7 | 257.4 | 259.9 | 174.7 | ||||||||||||
balance-sheet.row.long-term-debt-total | 26141.9 | 6788.2 | 6281 | 6274 | ||||||||||||
Deferred Revenue Non Current | 1460.2 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1765.1 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 11636.5 | 2533.3 | 2424.2 | 2446.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 32608.6 | 8611.1 | 7892.9 | 8619.4 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 1460.2 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.total-liab | 47266.6 | 12045.4 | 11165.7 | 12917.6 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0.4 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.retained-earnings | 69305.9 | 17627.6 | 16466.5 | 13911.7 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -657.8 | -153.7 | -164.9 | -106.7 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | -11101.8 | -2674.6 | -2903.8 | -2908.9 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 57546.7 | 14799.4 | 13397.9 | 10896.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 104793.2 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.minority-interest | -20.1 | 0 | -9.5 | 63.5 | ||||||||||||
balance-sheet.row.total-equity | 57526.6 | 14799.4 | 13388.4 | 10959.7 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 104793.2 | - | - | - | ||||||||||||
Total Investments | 10636.8 | 460.7 | 3430.6 | 4143.3 | ||||||||||||
balance-sheet.row.total-debt | 28342.4 | 7428.5 | 6711.2 | 7692.6 | ||||||||||||
balance-sheet.row.net-debt | 19488.6 | 6378.6 | 3291.9 | 5431.2 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 1161.1 | 1161.1 | 3046.9 | 1556.1 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 494.8 | 494.8 | 518.7 | 487.3 | ||||||||||||
cash-flows.row.deferred-income-tax | -305.8 | -305.8 | -168.6 | -426.8 | ||||||||||||
cash-flows.row.stock-based-compensation | 355.1 | -1063.8 | 264.3 | 250.8 | ||||||||||||
cash-flows.row.change-in-working-capital | -648.7 | -648.7 | -890.3 | -145.5 | ||||||||||||
cash-flows.row.account-receivables | 56.7 | 56.7 | -222.4 | 326 | ||||||||||||
cash-flows.row.inventory | -130.9 | -130.9 | -320.2 | -462.4 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-working-capital | -574.5 | -574.5 | -347.7 | -9.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 490.7 | 1909.6 | -1386.7 | 1918 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1547.2 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -7237.5 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.acquisitions-net | 12.3 | 12.3 | 595 | 28.1 | ||||||||||||
cash-flows.row.purchases-of-investments | -5140.7 | -5140.7 | -3448.5 | -3808.7 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 8288.5 | 8288.5 | 4661.3 | 3498.9 | ||||||||||||
cash-flows.row.other-investing-activites | -11.3 | -11.3 | 24.4 | 12.9 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -4088.7 | -4088.7 | 1589 | -563.7 | ||||||||||||
cash-flows.row.debt-repayment | -1487.3 | -187.3 | -1002.2 | -170 | ||||||||||||
cash-flows.row.common-stock-issued | -44.3 | -44.3 | -1.9 | -0.7 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -750 | -1800 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | -6 | -6 | -5.6 | -115.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 137 | 137 | -1759.7 | -2086.2 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 35.1 | 35.1 | -55.7 | -59.8 | ||||||||||||
cash-flows.row.net-change-in-cash | -2369.4 | -2369.4 | 1157.9 | 930.2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 8853.8 | 1049.9 | 3419.3 | 2261.4 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 11223.2 | 3419.3 | 2261.4 | 1331.2 | ||||||||||||
cash-flows.row.operating-cash-flow | 1547.2 | 1547.2 | 1384.3 | 3639.9 | ||||||||||||
cash-flows.row.capital-expenditure | -7237.5 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.free-cash-flow | -5690.3 | -5690.3 | 1141.1 | 3345 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 9417 | 9417 | 9433.4 | 10402.4 | ||||||||||||
income-statement-row.row.cost-of-revenue | 3028.2 | 3028.2 | 2797 | 2597 | ||||||||||||
income-statement-row.row.gross-profit | 6388.8 | 6388.8 | 6636.4 | 7805.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 2207.8 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 4757.5 | 4757.5 | 4362.3 | 4940.2 | ||||||||||||
income-statement-row.row.cost-and-expenses | 7785.7 | 7785.7 | 7159.3 | 7537.2 | ||||||||||||
income-statement-row.row.interest-income | 276.5 | 276.5 | 89.3 | 11 | ||||||||||||
income-statement-row.row.interest-expense | 246.9 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | -334.5 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | -334.5 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.interest-expense | 246.9 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 494.8 | 494.8 | 518.7 | 487.3 | ||||||||||||
income-statement-row.row.ebitda-caps | 2126.1 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 1631.3 | 1631.3 | 2274.1 | 2865.2 | ||||||||||||
income-statement-row.row.income-before-tax | 1296.8 | 1296.8 | 3591.8 | 1745.2 | ||||||||||||
income-statement-row.row.income-tax-expense | 135.3 | 135.3 | 632.8 | 52.5 | ||||||||||||
income-statement-row.row.net-income | 1161.1 | 1161.1 | 3046.9 | 1556.1 |
Често задавани въпроси
Какво е Biogen Inc (0R1B.L) общи активи?
Biogen Inc (0R1B.L) общите активи са 26844800000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 4734700000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -39.271.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -39.271.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.123.
Какъв е общият приход на предприятието?
Общият приход е 0.173.
Каква е Biogen Inc (0R1B.L) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 1161100000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 7428500000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 4757500000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 1049900000.000.